-84%

est. 2Y upside i

HealthcareSeed

Amigo is a comprehensive platform that empowers enterprises to build reliable, high-quality agents to scale their services teams with a focus on performance, scalability, and strategic alignment.

Rank

#275

Sector

Healthtech AI

Est. Liquidity

~5Y

Data Quality

Data: Medium

Amigo AI operates in a high-growth Healthtech AI market with a compelling vision to scale expert knowledge.

Last updated: March 10, 2026

Bull (30%)+400%

Amigo AI successfully scales its platform beyond initial partners, securing major contracts with large healthcare systems and expanding into new mission-critical sectors. Its proprietary agent architecture becomes a standard for safe and reliable clinical AI, driving revenue to $100M+ by 2028 and justifying a $300M+ valuation at 5x-6x revenue, well above the current $60M.

Base (45%)+75%

Amigo AI continues to grow steadily within its niche, securing additional partnerships in healthcare and demonstrating strong regulatory compliance. It achieves modest revenue growth to $20M-$30M by 2028, leading to a Series B or C round at a valuation of $100M-$120M, representing a reasonable return on the current valuation but facing ongoing competition.

Bear (25%)-80%

Dominant incumbents like Epic or Google launch more comprehensive and integrated AI agent platforms, or a well-funded competitor gains significant market share. Amigo AI struggles to differentiate or scale, leading to slower-than-expected growth, a challenging Series A fundraise, or a down round to $10M-$15M, significantly eroding common stock value given the $6.3M in liquidation preferences.

Est. time to liquidity~5.0 years

Preference Stack Risk

moderate

Investors hold $6.3M in liquidation preferences, representing 10.5% of the estimated current $60M valuation.

Dilution Risk

high

As a seed-stage company, Amigo AI will require multiple future funding rounds (Series A, B, C+) which will lead to significant dilution for common stock holders.

Secondary Liquidity

none

There is currently no active secondary market or tender offer for Amigo AI equity due to its early stage.

Engineering — 10 roles

Field — 6 roles

Research — 3 roles

People — 1 role

View all 34 open roles at Amigo →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Amigo's data — designed to show you've done your homework.

  • 1

    “How does Amigo AI plan to effectively compete with the AI initiatives of dominant incumbents like Epic and Google, particularly as they expand their own AI agent capabilities?”

  • 2

    “Given the high regulatory barriers in healthcare, what specific strategies and resources are in place to ensure continuous compliance and accelerate time-to-market for new clinical AI agents?”

  • 3

    “As a seed-stage company, what is the anticipated funding roadmap for the next 2-3 years, and how is the company planning to manage potential dilution for early employees?”

Community

Valuation Sentiment

Our model estimates -84% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.